Natural history studies of SMA and people with 4 SMN2 copies have shown substantial phenotypic variability in untreated individuals, ranging from onset of weakness in the first year to adulthood, albeit with functional deterioration with increasing age [34]. The gene discussed is SMN2; the disease is proximal spinal muscular atrophy.